PFE
PFIZER INC
NYSE · Healthcare · Drug Manufacturers - General · US
$29.44
−0.47%Oct 19, 2026, 15:00 UTC
Cboe Global Markets, Inc. launched extended pre-market and post-market trading sessions for selected U.S. single-stock and ETF options on its Cboe Global Markets, Inc..
Oct 16, 2026, 19:45 UTC
MetroLoft’s redevelopment plan for the PFIZER INC now calls for crews to jack up sagging floors gradually, ultimately raising them about seven inches.
Source:Oct 16, 2026, 14:00 UTC
PFIZER INC confirmed that about 150 workers at its Portage, Michigan, manufacturing facility are losing their jobs because of lower production volumes amid weaker demand for some products.
Source:Oct 14, 2026, 22:45 UTC
PFIZER INC shares rose 2.96% to close at $29.21 while the broader market dipped.
Source:Oct 14, 2026, 10:45 UTC
Pfizer announced that it will present data from more than 50 research abstracts, including 12 oral presentations, at PFIZER INC in Washington, D.C.
Source:Oct 13, 2026, 11:00 UTC
Enodia Therapeutics announced a research collaboration and license agreement with Pfizer to discover and develop Sec61 inhibitors using Enodia's proprietary platform.
Source:Oct 12, 2026, 14:56 UTC
PFIZER INC shares moved above their 50-day simple moving average.
Source:Oct 12, 2026, 07:56 UTC
China's National Medical Products Administration approved PFIZER INC's enoglutide injection for an additional indication in adults with type 2 diabetes.
Source:Oct 7, 2026, 16:57 UTC
The U.S. Food and Drug Administration approved Pfizer's TUKYSA regimen with trastuzumab and pertuzumab for maintenance treatment of adults with unresectable locally advanced or metastatic HER2-positive breast cancer following induction treatment.
Oct 7, 2026, 14:21 UTC
PFIZER INC plans to cut around 330 jobs at its plant in Sicily, according to labour unions.
Source:Oct 6, 2026, 14:00 UTC
Pfizer Inc.'s board of directors declared a $0.43 per share fourth-quarter 2026 dividend on its common stock, payable December 7, 2026 to shareholders of record as of November 6, 2026.
Source:Oct 5, 2026, 14:23 UTC
Vaxcyte shares spiked 57% after its lead vaccine candidate showed trial results positioning it against Pfizer and Merck.
Source:Oct 3, 2026, 14:45 UTC
A Russian air strike on Friday, Oct. 2 set fire to a pharmaceutical storage warehouse belonging to Ukrainian drug distributor Venta near Kyiv, destroying inventories of medicines made by Bayer, Sanofi, Pfizer, Teva, Darnytsia and Farmak.
Source:Oct 2, 2026, 15:17 UTC
Pfizer announced it will submit Litfulo (ritlecitinib) data for vitiligo to the FDA and EMA.
Source:Oct 2, 2026, 15:15 UTC
Pfizer presented results from two Phase 3 trials showing that LITFULO (ritlecitinib) 100 mg and 50 mg significantly improved facial and total body repigmentation versus placebo in patients with nonsegmental vitiligo.
Source:Oct 1, 2026, 22:46 UTC
Pfizer (PFE) shares closed at $28.10, down 1.47% from the previous trading session.
Source:Oct 1, 2026, 18:00 UTC
Florida Attorney General James Uthmeier filed a lawsuit against Pfizer and CEO Albert Bourla, alleging the company misled consumers about the safety and effectiveness of its COVID-19 vaccine.
Oct 1, 2026, 06:30 UTC
Pfizer presented detailed Phase 2 results showing tilrekimig (PF-07275315) met its primary endpoint with significant EASI-75 skin clearance at Week 16 in adults with moderate-to-severe atopic dermatitis.
Source:Sep 29, 2026, 13:30 UTC
Republican Ron Schutz, candidate for Minnesota attorney general, disclosed a stock portfolio of more than $10,000 in each of 174 companies worth at least $1.74 million, creating potential conflicts of interest with corporations the office litigates.
Source:Sep 28, 2026, 23:00 UTC
New York City Mayor Zohran Mamdani's City Hall advisers are planning a coordinated pressure campaign against top New York business executives, including Partnership for New York City CEO Steve Fulop, Pfizer CEO Albert Bourla and Related Companies CEO Jeff Blau, to build support for his tax-the-rich agenda.
Source:Sep 28, 2026, 22:00 UTC
The U.S. CDC reinstated its earlier, broader COVID-19 vaccine recommendations, including for children and younger adults, in compliance with a March 2026 court stay, even though some uses are off-label relative to FDA approvals.
Source:Sep 28, 2026, 10:45 UTC
Pfizer announced it will present data from 45 research abstracts, including 11 oral presentations, at the European Society for Medical Oncology (ESMO) Congress in Madrid on October 23-27, 2026.
Source:Sep 27, 2026, 23:59 UTC
Pfizer granted $400,000 to the American Society for Meningitis Prevention and $100,000 to the March of Dimes Foundation for vaccine policy efforts, and both organizations later signed a June 1 letter supporting Massachusetts bill H.2554 to eliminate non-medical school vaccine exemptions.
Source:Sep 27, 2026, 08:30 UTC
U.S. consumer advocacy group Public Citizen posted copies of Pfizer's and Eli Lilly's most favoured nation pricing agreements with the Trump administration that it sued to obtain.
Source:Sep 23, 2026, 16:00 UTC
Pfizer reported Q1 2026 revenue of $14.45B, up 5.4%, with adjusted EPS of $0.75, as growth in Padcev, Nurtec and oncology biosimilars offset declines in Comirnaty and Paxlovid.
Source:Sep 23, 2026, 14:00 UTC
Pfizer generated $3.45 billion of operating cash flow in Q2 and returned $4.9 billion to shareholders via dividends in the first half of 2026.
Source:Sep 19, 2026, 11:00 UTC
Public Citizen sued the Trump administration under the Freedom of Information Act to obtain documents on confidential drug-pricing deals with Pfizer and Eli Lilly, and is litigating to challenge the administration's redactions.
Source:
Page 1Next →